Insider Transactions in Q3 2024 at Janux Therapeutics, Inc. (JANX)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Direct |
958
-12.21%
|
$44,068
$46.24 P/Share
|
|
Sep 30
2024
|
Avalon Ventures Xi, L.P. |
BUY
Exercise of conversion of derivative security
|
Direct |
919
+2.94%
|
$18,380
$20.19 P/Share
|
|
Sep 27
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Direct |
49,231
-7.51%
|
$2,264,626
$46.78 P/Share
|
|
Sep 27
2024
|
Avalon Ventures Xi, L.P. |
BUY
Exercise of conversion of derivative security
|
Direct |
1,752
+5.03%
|
$35,040
$20.19 P/Share
|
|
Sep 27
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Indirect |
57,590
-0.83%
|
$2,706,730
$47.08 P/Share
|
|
Sep 27
2024
|
David Alan Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-2.55%
|
$1,150,000
$46.93 P/Share
|
|
Sep 27
2024
|
Thomas Di Raimondo Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,000
-2.44%
|
$230,000
$46.72 P/Share
|
|
Sep 27
2024
|
Andrew Hollman Meyer Chief Business Officer |
SELL
Open market or private sale
|
Direct |
50,000
-42.52%
|
$2,250,000
$45.96 P/Share
|
|
Sep 27
2024
|
Andrew Hollman Meyer Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+29.83%
|
$200,000
$4.21 P/Share
|
|
Sep 26
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Indirect |
109,700
-1.54%
|
$5,155,900
$47.28 P/Share
|
|
Sep 26
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Direct |
90,300
-1.54%
|
$4,244,100
$47.28 P/Share
|
|
Sep 13
2024
|
Jay Lichter |
SELL
Open market or private sale
|
Direct |
3,815
-35.28%
|
$175,490
$46.68 P/Share
|
|
Sep 13
2024
|
Jay Lichter |
BUY
Exercise of conversion of derivative security
|
Direct |
3,815
+8.82%
|
$76,300
$20.19 P/Share
|
|
Sep 12
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Indirect |
191,969
-5.07%
|
$9,022,543
$47.0 P/Share
|
|
Sep 12
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Direct |
158,031
-5.07%
|
$7,427,457
$47.0 P/Share
|
|
Sep 10
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Indirect |
55,446
-0.72%
|
$2,550,516
$46.4 P/Share
|
|
Sep 10
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Direct |
45,645
-0.72%
|
$2,099,670
$46.4 P/Share
|
|
Sep 09
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Direct |
2,182
-23.76%
|
$91,644
$42.33 P/Share
|
|
Sep 09
2024
|
Avalon Ventures Xi, L.P. |
BUY
Exercise of conversion of derivative security
|
Direct |
2,099
+5.74%
|
$41,980
$20.19 P/Share
|
|
Sep 06
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Indirect |
131,635
-3.31%
|
$5,528,670
$42.0 P/Share
|
|
Sep 06
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Direct |
108,365
-3.31%
|
$4,551,330
$42.0 P/Share
|
|
Jul 19
2024
|
Eric Dobmeier |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+37.5%
|
-
|
|
Jul 19
2024
|
Natasha Hernday |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+37.5%
|
-
|